Avenue Therapeutics, Inc. - ATXI Biznesning balans bahosi

Avenue Therapeutics, Inc. (ATXI) kompaniyasining rasmiy ramzlari

Avenue Therapeutics (ATXI) uchun mavjud narx harakati vektori 0.00 ko'rsatkichidagi aktivlar dinamikasini aks ettiradi. Avenue Therapeutics (ATXI) atrof-muhitga bo'lgan ta'sirni minimallashtirish uchun neyropsixiatrik agentlarni ishlab chiqishda bioetik standartlarni joriy qilmoqda. Ishlab chiquvchi xavfsiz opioid alternativlarini tadqiq qilgani uchun tan olingan. Biznes hozirda arzon generik ishlab chiqaruvchilarning kengayishidan o'z pozitsiyasini himoya qilish uchun shifoxona darajasidagi dori formulalarini patentlashga e'tibor qaratmoqda.

ATXI: Avenue Therapeutics, Inc. Balans kapitallashuvi 04.07.2022 - 29.03.2025

ATXI (Avenue Therapeutics, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Aksiya kursi Avenue Therapeutics Inc|ATXI - Tahlilchilar konsensus prognozi
- emitentning bozor qiymati haqida ma'lumotlar:
Bozor kapitallashuvi Avenue Therapeutics Inc.|ATXI - Kompaniyaning to‘liq qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga xususiy kapital Avenue Therapeutics|ATXI - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti avenuetx.com|ATXI - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Avenue Therapeutics|ATXI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Avenue Therapeutics Inc.|ATXI - Kompaniya qarzlari|Balans qiymatiga qarzlar Avenue Therapeutics Inc.|ATXI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Avenue Therapeutics|Tezkor likvidlik avenuetx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATXI - Sof foyda
Kompaniyaning dastlabki tahlili:ATXI, Avenue Therapeutics Inc
Avenue Therapeutics Inc. seriyali mahsuloti

Fundamental barqarorlik omillarini aniqlash uchun investorlar kompaniyaning umumiy aktivlari va barcha majburiyatlari o'rtasidagi farqni tahlil qilishlari kerak, bu esa sof aktivlarning haqiqiy qiymatini aks ettiradi. Ushbu balans qiymati ko'rsatkichi Avenue Therapeutics (ATXI) kompaniyasining moddiy bazasini namoyish etib, kompaniyaning tadqiqot va ishlanmalar (R&D) tashabbuslarini qo'llab-quvvatlash hamda uzoq muddatli opsion dasturlari orqali yetakchi markaziy nerv tizimi (CNS) tadqiqotchilarini saqlab qolish bo'yicha moliyaviy imkoniyatlarini tasdiqlaydi.

Avenue Therapeutics raqobatchilari tahlili

BIIB (Biogen Idec) - Buxgalteriya kapitallashuvi|NBIX: Balans kapitallashuvi|RGC - Biznesning balans bahosi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc.|Buxgalteriya kapitallashuvi ACAD (ACADIA Pharma)|Balans kapitallashuvi XENE|VKTX - Kompaniyaning xususiy kapitali|Supernus Pharmaceuticals - Kompaniyaning sof aktivlari|Balans kapitallashuvi catalystpharma.com CPRX|DNLI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali Amylyx Corp (AMLX)|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi praxismedicines.com|Kompaniyaning sof aktivlari AVXL (Anavex Life Sciences Corp.)|Kompaniyaning balans qiymati CBLL (CeriBell Inc)|Balans kapitallashuvi PRTA (prothena.com)|Alector Inc. (ALEC) - Kompaniyaning xususiy kapitali|ANNX - Kompaniyaning balans qiymati|OMER (Omeros Corporation) - Buxgalteriya kapitallashuvi|NGNE (Neurogene) - Kompaniyaning sof aktivlari|AC Immune S.A. (ACIU) - Balans kapitallashuvi|VYGR (Voyager Pharma) - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Neumora Corp NMRA|Kompaniyaning sof aktivlari SCLX (Scilex Holding Company)|TVGN (tevogen.com) - Kompaniyaning buxgalteriya qiymati|Alpha Cognition Inc. - Kompaniyaning sof aktivlari|Jami sof aktivlar CGTX (cogrx.com)|Inhibikase - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati SAVA (Cassava Pharma)|ASRT: Balans kapitallashuvi|Kompaniyaning xususiy kapitali Coya Therapeutics (COYA)|Kompaniyaning balans qiymati VistaGen Therapeutics, Inc.|OVID: Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi ABOS|Balans kapitallashuvi CervoMed Corporation (CRVO)|Kompaniyaning balans qiymati Alterity Therapeutics Limited ATHE|CLNN (Clene Inc) - Sof aktivlar qiymati|PepGen Corp - Balans kapitallashuvi|Kompaniyaning xususiy kapitali jupiterneurosciences.com|RLMD (Relmada) - Kompaniyaning sof aktivlari|Annovis Bio Corporation (ANVS) - Balans kapitallashuvi|Kompaniyaning sof aktivlari GRCE|AIFF (fireflyneuro.com) - Jami sof aktivlar|Balans kapitallashuvi KLTO|Biznesning balans bahosi neurosense-tx.com|Balans kapitallashuvi RVPH (Reviva Pharmaceuticals Holdings)|MTVA - Kompaniyaning sof aktivlari|NRXS - Kompaniyaning balans qiymati|Biznesning balans bahosi Helius Medical HSDT|PASG: Balans kapitallashuvi|Neuphoria Therapeutics (NEUP) - Balans kapitallashuvi|Kompaniyaning sof aktivlari NERV|ATHA (Athira Pharma Corp) - Jami sof aktivlar|Kompaniyaning sof aktivlari ADXN (Addex Therapeutics)|alzamend.com - Buxgalteriya kapitallashuvi|Balans kapitallashuvi CYCN (Cyclerion Therapeutics, Inc.)|Biznesning balans bahosi Protagenic Therapeutics Inc. (PTIX)|KTTA - Kompaniyaning balans qiymati|CRGT (Cortigent, Inc.) - Buxgalteriya kapitallashuvi|BCLI: Balans kapitallashuvi|Kompaniyaning xususiy kapitali caratherapeutics.com (CARA)|Kompaniyaning sof aktivlari CHRO|Balans kapitallashuvi Eliem|Kompaniyaning balans qiymati Intra-Cellular Therapies (ITCI)|LBPH (Longboard) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Marinus Pharmaceuticals MRNS|nkgenbiotech.com (NKGN) - Kompaniyaning xususiy kapitali|NeuroBo Pharmaceuticals, Inc. - Balans kapitallashuvi|SAGE - Balans kapitallashuvi|SNPX (Neurotrope) - Kompaniyaning sof aktivlari|TRVN (Trevena Inc) - Kompaniyaning balans qiymati|VIGL (Vigil Neuroscience Inc.) - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Anew Medical Inc. WENA|Kompaniyaning balans qiymati Cerevel Therapeutics, Inc. (CERE)